A Prospective Longitudinal Study of Immunoreactive Prostacyclin and Thromboxane Metabolites in Normal and Hypertensive Pregnancy

References

• Armstrong J.M., Lattimer N., Moncada S., Vane J.R. “Comparison of the vasodepressor effects of prostacyclin and 6-oxo-Prostaglandin F1 with those of prostaglandin E2 in rats and rabbits” Br. J. Pharmacol. 1978; 62: 125
   Google Scholar
• Belch J.J.F., Greer I., McLaren M., Walker J., Forbes C.D. “Measurement of prostacyclin metabolites”. Lancet 1983; ii: 1504
   Google Scholar
• Blair I.A., Barrow S.E., Waddell K.A., Lewis P.J., Dollery C.T. Prostacyclin is not a circulating hormone in man. Prostaglandins 1982; 23: 579
   PubMed Web of Science ®Google Scholar
• Bolton P.J., Jogee M., Myatt L., Elder M.G. “Maternal plasma 6-oxo-prostaglandin F1 levels throughout pregnancy; a longitudinal study”. Br. J. Obstet. Gynaecol. 1981; 88: 1101
   PubMedGoogle Scholar
• Bunting S., Moncada S., Vane J.R. The effects of prostglandin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and other smooth muscle preparations. Br. Pharmacol. 1976; 57: 462
   PubMed Web of Science ®Google Scholar
• Bunting S., Moncada S., Vane J.R. “The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications”. Br. Med. Bull. 1983; 39: 271
   PubMed Web of Science ®Google Scholar
• Bussolino F., Benedetto C., Massobrio M., Camussi G. Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 1980; ii: 702
   Google Scholar
• Downing I., Shepherd G.L., Lewis P.J. “Reduced prostacyclin production in pre-eclampsia. Lancet 1980; ii: 1374
   Google Scholar
• Dusting G., Moncada S., Vane J.R. “Vascular actions of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog”. Eur. J. Pharmacol. 1978; 49: 65
   PubMedGoogle Scholar
• Dusting G.J., Moncada S., Vane J.R. “Disappearance of prostacyclin (PGI2) in the circulation of the dog. Br. J. Pharmacol. 1979; 62: 414p
   Google Scholar
• Fidler J., Bennett M.J., de Swiet M., Ellis C., Lewis P.J. Treatment of pregnancy hypertension with prostacyclin. Lancet 1980; i: 31
   Google Scholar
• Gant N.F., Daley G.L., Chand S., Whalley P.J., Macdonald P.C. “A study of angiotensin II pressor response throughout primigravid pregnancy”. J. Clin. Invest. 1973; 52: 2682
   PubMed Web of Science ®Google Scholar
• Goodman R.P., Killam A.P., Brash A.R., Branch R.A. “Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension”. Am. J. Obstet. Gynecol. 1982; 142: 817
   PubMed Web of Science ®Google Scholar
• Granstrom L., Kindahl H. Radioimmunoassay of prostaglandins and thromboxane. Advances in prostaglandin and thromboxane research 1978; 5: 119
   PubMedGoogle Scholar
• Greaves M., Preston F.E. “Plasma 6-keto-PGF1 : Fact or Fiction”. Thromb. Res. 1982; 26: 145
   PubMedGoogle Scholar
• Greer I.A., Walker J.J., McLaren M., Bonduelle M., Cameron A.D., Calder A.A., Forbes C.D. Immunoreactive prostacyclin and thromboxane metabolites in normal pregnancy and the puerperium. Br. J. Obstet. Gynaecol., in press
   Google Scholar
• Hamberg M., Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc. Natl. Acad. Sci. U.S.A 1973; 70: 889
   Google Scholar
• Hamberg M., Svensson J., Samuelsson B. “A new group of biologically active compounds derived from prostaglandin endoperoxides”. Proc. Natl, Acad. Sci. U.S.A 1975; 72: 2994
   PubMed Web of Science ®Google Scholar
• Hamberg M., Svensson J., Wakabayashi Samuelsson T.B. “Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation”. Proc. Natl. Acad. Sci. U.S.A 1972; 71: 345
   Google Scholar
• Hensby C.N., Fitzgerald G.A., Friedman L.A., Lewis P.J., Dollery C.T. “Measurement of 6-oxo-PGF1 in human plasma using gas chromatogrpahy-mass spectometry”. Prostaglandins 1979; 18: 731
   PubMedGoogle Scholar
• Higgs E.A., Higgs G.A., Moncada S., Vane J.R. “Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch”. Br. J. Pharmacol. 1978; 63: 535
   PubMedGoogle Scholar
• Jogee M., Myatt L., Elder M.G. “Decreased Prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardation”. Br. J. Obstet. Gynaecol. 1983; 90: 247
   PubMedGoogle Scholar
• Johnson R.A., Morton D.R., Kinner J.H., Gorman R.R., McGuire J.R., Sun F.F., Whittaker W., Bunting S., Salmon J.A., Moncada S., Vane J.R. The chemical structure of prostaglandin X (prostacyclin). Prostaglandins 1976; 12
   PubMedGoogle Scholar
• Lewis P.J., Boylan P., Friedman L.A., Hensby C.N., Downing I. “Prostacyclin in pregnancy.”. Br. Med. J. 1980; 280: 1581
   PubMed Web of Science ®Google Scholar
• Lewis P.J., Shepherd G.L., Ritter J., Chan S.M.T., Bolton P.J., Jogee M., Myatt L., Elder M.G. “Prostacyclin and pre-eclampsia.”. Lancet 1981; i: 559
   Google Scholar
• Makila U.M., Jouppila P., Kirkinen P., Viinikka L., Ylikorkala O. “Relation between umbilical prostacyclin production and blood flow in the fetus.”. Lancet 1983; i: 728
   Google Scholar
• MacIntyre D.E., Pearson J.D., Gordon J.L. “Localisation and stimulation of prostacyclin production in vascular cells.”. Nature 1978; 271: 549
   PubMed Web of Science ®Google Scholar
• McLaren M., Belch J.J.F., Forbes C.D., Prentice C.R.M. “Development of a radioimmunoassay for the measurement of prostacyclin metabolites in unextracted plasma. Thromb. Res. 1985; 37: 177
   PubMedGoogle Scholar
• Mitchell M.D. “A sensitive radioimmunoassay for 6-keto-prostaglandin-F1 : preliminary observations on circulating concentrations. Prostagland. Med. 1978; 1: 12
   Google Scholar
• Mitchell M.D. Prostacyclin during human pregnancy and paturition. Clinical Pharmacology of Prostacyclin, P. J. Lewis, J. O'Grady. Raven Press, New York 1981; 121
   Google Scholar
• Mitchell M.D., Bibby J.G., Hicks B.R., Redman C.W.G., Anderson A.B.M., Turnbull A.C. “Thromboxane B2 and human parturition: concentrations in the plasma and production in vitro.”. J. Endocrinol. 1978; 78: 435
   PubMed Web of Science ®Google Scholar
• Miyamori I., Fitzgerald G.A., Brown M.J., Lewis P.J. “Prostacyclin stimulates the renin angiotensin aldosterone system in man.”. J. Clin. Endocrinol. Metab. 1979; 49: 943
   PubMed Web of Science ®Google Scholar
• Moncada S., Gryglewski R.J., Bunting S., Vane J.R. “An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663
   PubMed Web of Science ®Google Scholar
• Moncada S., Herman A.G., Higgs E.A., Vane J.R. “Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall: an explanation for the anti-thrombotic properties of vascular endothelium.”. Thromb. Res. 1977; 11: 323
   PubMed Web of Science ®Google Scholar
• Moncada S., Korbut R., Bunting S., Vane J.R. “Prostacyclin is a circulating hormone.”. Nature 1978; 273: 767
   PubMed Web of Science ®Google Scholar
• Patrono C., Preston F.E., Vermylen J. “Platelet and vascular arachidonic acid metabolites: can they help detect a tendency towards thrombosis?”. Br. J. Haematol. 1984; 57: 209
   PubMedGoogle Scholar
• Rakoczi I., Tihanyi K., Falkay G., Rozsa I., Demeser J., Grati I. Prostacyclin production in trophoblast. Prostacyclin in pregnancy, P. J. Lewis, S. Moncada, J. O'Grady. Raven Press, New York 1983; 15
   Google Scholar
• Remuzzi G., Marchesi D., Zoja C, Muratore D., Mecca G., Misiani R., Rossi E., Barbato M., Capetta P., Donati M.B., de Gaetano G. “Reducted umbilical and placental vascular prostacyclin in severe pre-eclampsia.”. Prostaglandins 1980; 20: 105
   PubMed Web of Science ®Google Scholar
• Remuzzi G., Misiani R., Muratore D., Marchesi D., Livio M., Schiepatti A., Mecca G., de Gaetano G., Donati M.B. “Prostacyclin and human foetal circulation.”. Prostaglandins 1979; 18: 341
   PubMed Web of Science ®Google Scholar
• Remuzzi G., Zoja C., Marchesi D., Mecca G., Misiani R., Schieppati A., Donati M.B., De Gaetano G. “Plasmatic regulation of vascular prostacyclin in pregnancy.”. Br. Med. J. 1981; 282: 512
   PubMed Web of Science ®Google Scholar
• Ritter J.M., Blair I.A., Barrow S.E., Dollery C.T. “Release of prostacyclin in vivo and its role in man. Lancet 1983; i: 317
   Google Scholar
• Roy A.C., Karim S.M.M., Kottegoda S.R., Ratnam S.S. “Thromboxane A2 and prostacyclin levels in molar pregnancy.”. Br. J. Obstet. Gynaecol. 1984; 9: 908
   Google Scholar
• Salmon J.A. “Measurement of elcosanoids by bioassay and radioimmunoassay.”. Br. Med. Bull. 1983; 39: 227
   PubMed Web of Science ®Google Scholar
• Stuart M.J., Sunderji S.G., Yambo T., Clark D.A., Allen J.B., Eldrad H., Slott J.H. “Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes.”. Lancet 1981; i: 1126
   Google Scholar
• Tuveno T. “Role of prostaglandins, prostacyclin and thromboxanes in the control of the umbilical-placental circulation.”. Semin. Perinatol. 1980; 4: 91
   PubMedGoogle Scholar
• Ubatuba F.B., Moncada S., Vane J.R. “The effect of prostacyclin (PGI2) on platelet behaviour, thrombus formation in vivo, and bleeding time. Thromb. Diath. Haemorrh. 1979; 41: 425
   Google Scholar
• Viinikka L., Ylikorkala O. “Different results of plasma 6-keto-PGF1 measurements utilising two antisera with apparently similar specificity.”. Prost. Leuk. Med. 1982; 9: 1
   PubMedGoogle Scholar
• Weksler B.B., Jaffe A.J., Marcus E.A. “Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.”. Proc. Natl. Acad. Sci, U.S.A. 1977; 74: 3922
   PubMed Web of Science ®Google Scholar
• Ylikorkala O., Viinikka L. “Thromboxane A2 in pregnancy and puerperium.”. Br. Med. J. 1980; 281: 1601
   PubMedGoogle Scholar
• Ylikorkala O., Viinikka L. Maternal plasma levels of 6-keto- prostaglandin F1 during pregnancy and puerperium. Prostagl. Med. 1981; 7: 95
   PubMedGoogle Scholar